Resolution of Osseous Sarcoidosis with Methotrexate
Joint Authors
Kanner, Christopher
Libman, Bonita
Merchand, Morgan
Lemos, Diego
Source
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-5, 5 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-11-11
Country of Publication
Egypt
No. of Pages
5
Main Subjects
Abstract EN
Though a relatively uncommon manifestation of sarcoidosis, some clinicians are tasked with managing osseous involvement of disease, and the optimal treatment approach in this setting is not well established.
Previous studies have shown variable efficacy for osseous sarcoidosis utilizing multiple agents alone or in combination, often using imaging follow-up in conjunction with clinical assessment to evaluate response to treatment.
We present a case of widespread skeletal involvement of sarcoidosis without evidence of concurrent pulmonary disease demonstrating marked clinical improvement and near-complete resolution of imaging abnormalities on magnetic resonance imaging (MRI) following the use of methotrexate as the primary pharmacologic agent.
American Psychological Association (APA)
Kanner, Christopher& Libman, Bonita& Merchand, Morgan& Lemos, Diego. 2019. Resolution of Osseous Sarcoidosis with Methotrexate. Case Reports in Rheumatology،Vol. 2019, no. 2019, pp.1-5.
https://search.emarefa.net/detail/BIM-1144217
Modern Language Association (MLA)
Kanner, Christopher…[et al.]. Resolution of Osseous Sarcoidosis with Methotrexate. Case Reports in Rheumatology No. 2019 (2019), pp.1-5.
https://search.emarefa.net/detail/BIM-1144217
American Medical Association (AMA)
Kanner, Christopher& Libman, Bonita& Merchand, Morgan& Lemos, Diego. Resolution of Osseous Sarcoidosis with Methotrexate. Case Reports in Rheumatology. 2019. Vol. 2019, no. 2019, pp.1-5.
https://search.emarefa.net/detail/BIM-1144217
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1144217